Skip to main content
Kiran Patel, MD, Radiology, Oceanside, CA, Palomar Medical Center Escondido

KiranRoshanPatelMD

Radiology Oceanside, CA

Physician

Are you Dr. Patel?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 66 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Kiran Patel, MD is a board certified radiologist in Oceanside, California. He is currently licensed to practice medicine in California, New Mexico, and Maryland. He is affiliated with Tri-City Medical Center, Palomar Medical Center Escondido, and Palomar Medical Center Poway.

Education & Training

  • Mount Auburn Hospital
    Mount Auburn HospitalResidency, Radiology-Diagnostic, 2004 - 2008
  • West Suburban Medical Center
    West Suburban Medical CenterInternship, Transitional Year, 2003 - 2004
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2024
  • NM State Medical License
    NM State Medical License 2017 - 2023
  • MD State Medical License
    MD State Medical License 2008 - 2009
  • IL State Medical License
    IL State Medical License 2003 - 2004
  • American Board of Radiology Diagnostic Radiology

Press Mentions

  • Morphogenesis, with a Potential Game-Changer for Skin Cancer, Raises $2.7 Million
    Morphogenesis, with a Potential Game-Changer for Skin Cancer, Raises $2.7 MillionDecember 18th, 2020
  • Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus Chemotherapy
    Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus ChemotherapyOctober 25th, 2023

Hospital Affiliations